MaltSci 麦伴科研

Appearance

Popular Reports / microbiology

This report is written by MaltSci based on the latest literature and research findings

What are the mechanisms of viral pathogenesis? ​

Abstract ​

Viral pathogenesis is a complex interplay between viral factors and host responses, leading to a spectrum of diseases ranging from mild to severe. Understanding the mechanisms by which viruses induce disease is crucial for developing effective therapeutic strategies and vaccines. This review systematically addresses the mechanisms of viral pathogenesis, including direct cytopathic effects, immune evasion strategies, and manipulation of host cell signaling pathways. It explores specific viral families—RNA viruses, DNA viruses, and retroviruses—and their unique pathogenic mechanisms, highlighting the importance of these distinctions for targeted therapeutic approaches. Additionally, host factors such as genetic susceptibility and environmental influences are examined to illustrate their role in modulating disease outcomes. The review concludes with a discussion on current therapeutic implications and future research directions aimed at combating viral infections. By enhancing our understanding of viral biology and host-pathogen interactions, this work aims to inform public health strategies and improve therapeutic interventions for viral diseases.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Mechanisms of Viral Pathogenesis
    • 2.1 Direct Cytopathic Effects
    • 2.2 Immune Evasion Strategies
    • 2.3 Manipulation of Host Cell Signaling Pathways
  • 3 Viral Families and Their Pathogenic Mechanisms
    • 3.1 RNA Viruses
    • 3.2 DNA Viruses
    • 3.3 Retroviruses
  • 4 Host Factors Influencing Viral Pathogenesis
    • 4.1 Genetic Susceptibility
    • 4.2 Environmental Influences
  • 5 Therapeutic Implications and Future Directions
    • 5.1 Current Therapeutic Approaches
    • 5.2 Future Research Directions
  • 6 Conclusion

1 Introduction ​

Viral pathogenesis is a complex interplay between viral factors and host responses, resulting in a spectrum of diseases that can range from mild to severe. The mechanisms by which viruses induce disease are multifaceted, encompassing direct cytopathic effects, immune evasion strategies, and manipulation of host cell signaling pathways. Understanding these mechanisms is crucial for the development of effective therapeutic strategies and vaccines. As the global burden of viral infections continues to rise, elucidating the intricate dynamics of host-virus interactions becomes increasingly imperative for public health.

The significance of studying viral pathogenesis lies not only in the immediate health implications but also in the long-term consequences of viral infections. For instance, chronic infections such as those caused by hepatitis viruses can lead to severe liver diseases, including hepatocellular carcinoma [1]. Similarly, emerging viruses like SARS-CoV-2 have shown to cause not only acute respiratory illness but also long-term sequelae, known as Long COVID, which presents new challenges for healthcare systems [2]. Understanding the molecular mechanisms of viral pathogenesis will provide insights into the disease process and facilitate the identification of novel therapeutic targets.

Current research in viral pathogenesis highlights several key areas of interest. Direct cytopathic effects are often the first line of investigation, as many viruses induce cell death through various mechanisms, including apoptosis and necrosis [3][4]. Additionally, immune evasion strategies employed by viruses complicate the host's ability to mount an effective immune response. For example, viruses like hepatitis C exploit host factors to modulate immune signaling pathways, allowing them to persist in the host [5][6]. Furthermore, the manipulation of host cell signaling pathways has emerged as a critical area of study, with evidence suggesting that viral proteins can directly interact with cellular machinery to alter gene expression and cellular functions [7].

This review is organized into several sections that will systematically address the mechanisms of viral pathogenesis. The first section will delve into the various mechanisms through which viruses exert their pathogenic effects, including direct cytopathic effects, immune evasion strategies, and manipulation of host cell signaling pathways. Following this, we will explore specific viral families—RNA viruses, DNA viruses, and retroviruses—and their unique pathogenic mechanisms. Understanding these distinctions is essential for developing targeted therapeutic approaches. The subsequent section will examine host factors that influence viral pathogenesis, including genetic susceptibility and environmental influences, highlighting how these factors can modulate disease outcomes. Finally, we will discuss current therapeutic implications and future research directions aimed at combating viral infections.

By providing a comprehensive overview of viral pathogenesis, this review aims to enhance our understanding of the fundamental aspects of viral biology and host-pathogen interactions. This knowledge is crucial not only for the development of effective vaccines and antiviral therapies but also for preparing public health strategies to mitigate the impact of viral diseases in the future. As we navigate the complexities of viral pathogenesis, the insights gained from this research will pave the way for innovative solutions to combat viral infections and their associated diseases.

2 Mechanisms of Viral Pathogenesis ​

2.1 Direct Cytopathic Effects ​

Viral pathogenesis encompasses a range of mechanisms through which viruses induce disease in their hosts. One of the primary mechanisms is the direct cytopathic effect resulting from viral replication. This effect is characterized by the persistent infection of host tissues, leading to various pathological conditions.

Human cytomegalovirus (HCMV), for example, can cause direct cytopathic effects manifested as persistent infections in neural or gastrointestinal tissues. This can lead to serious conditions such as HCMV retinitis, encephalitis, hepatitis, or gastroenteritis. The cytopathic effects are particularly pronounced in cases associated with congenital infections or in individuals with immune deficiencies, where the virus replicates unabated, resulting in significant tissue damage (Zaia 1990) [8].

In addition to direct cytopathic effects, viruses can also manipulate host cell functions in ways that inhibit gene expression, contributing to their pathogenicity. For instance, RNA viruses have been shown to interfere with host gene expression, which can prevent the host's antiviral responses. This phenomenon, termed "cytopathogenesis," includes not only visible cytopathic effects but also other cellular changes that may not be immediately apparent. The inhibition of host gene expression by viral products serves to suppress the host's immune response, facilitating viral persistence and pathogenesis (Lyles 2000) [9].

Furthermore, the activation of programmed cell death (PCD) pathways by viruses also plays a critical role in their pathogenesis. Viruses can induce various forms of PCD, including apoptosis, necroptosis, and pyroptosis, which can have significant implications for both viral replication and the host's immune response. The modulation of these pathways by viruses can directly affect tissue damage and the overall outcome of the infection (Verburg et al. 2022) [4].

Collectively, these mechanisms highlight the complexity of viral pathogenesis, where direct cytopathic effects, inhibition of host gene expression, and manipulation of cell death pathways interact to determine the severity and outcome of viral infections. Understanding these mechanisms is essential for developing effective therapeutic strategies against viral diseases.

2.2 Immune Evasion Strategies ​

Viral pathogenesis involves complex interactions between viruses and host immune systems, wherein viruses have evolved sophisticated mechanisms to evade immune detection and response. These immune evasion strategies are critical for viral survival and replication, and they significantly influence the severity and outcome of viral infections.

One primary strategy employed by viruses is the dysregulation of innate immune responses. Many RNA and DNA viruses have developed mechanisms to manipulate the post-translational modifications that are crucial for the activation of RIG-I-like receptors (RLRs), which are key sensors in the innate immune system. For instance, viruses can directly target ubiquitin E3 ligases, utilize viral deubiquitinating enzymes (DUBs) to remove ubiquitin modifications, or upregulate cellular DUBs that negatively regulate RLR signaling [10]. Additionally, certain coronaviruses, including SARS-CoV-2, actively deISGylate molecules within the RLR pathway, thereby escaping type I interferon (IFN)-mediated antiviral responses [10].

Another significant mechanism of immune evasion involves the sequestration or modification of viral nucleic acids to escape detection by pattern recognition receptors (PRRs). Viruses may interfere with specific post-translational modifications of PRRs or their adaptor proteins, degrade or cleave these receptors, or relocalize them away from sites of viral replication [11]. This interference with PRR function prevents the effective initiation of antiviral signaling, which is essential for triggering the production of antiviral genes.

Moreover, many viruses employ strategies to inhibit the expression or function of major histocompatibility complex class I (MHC-I) molecules. This inhibition prevents the presentation of viral peptides to CD8+ T-cells, thereby evading adaptive immune responses. Mechanisms include the suppression of MHC-I synthesis, degradation, and transport, which leads to decreased surface expression of MHC-I during viral infections [12].

Additionally, viral pathogens can manipulate host immune responses through the regulation of apoptosis and autophagy. By modulating these processes, viruses can create a more favorable environment for their replication. For instance, some viruses exploit the apoptotic pathways to promote their own survival while simultaneously inhibiting the host's immune response [13].

Viral mimicry of host factors is another tactic that facilitates immune evasion. By mimicking host proteins, viruses can manipulate host signaling pathways and evade immune detection [13]. This co-evolutionary strategy underscores the dynamic relationship between viruses and their hosts, as both evolve in response to each other's adaptations.

Finally, the induction of immune tolerance through chronic infections is also a critical mechanism of immune evasion. Viruses can persist in the host for extended periods, often leading to a state of immune tolerance that reduces the effectiveness of the immune response against them [14].

Understanding these diverse mechanisms of viral immune evasion is crucial for developing new antiviral therapies and vaccines. Targeting the specific viral proteins that manipulate immune responses may offer novel therapeutic strategies to enhance host immunity and combat viral infections [15].

2.3 Manipulation of Host Cell Signaling Pathways ​

Viral pathogenesis involves a complex interplay between viruses and host cells, where viruses manipulate host cellular processes to facilitate their replication and survival. One of the primary strategies employed by viruses is the manipulation of host cell signaling pathways, which can significantly alter the host's physiological responses and immune defenses.

Viruses exploit various eukaryotic signaling pathways during infection, often targeting signaling molecules that regulate multiple cellular processes. This manipulation is critical for the virus's ability to establish infection, replicate, and evade host immune responses. For instance, viruses have evolved mechanisms to hijack, mimic, or otherwise manipulate cellular processes such as the cell cycle, DNA damage repair, and cellular metabolism. These interactions are not only vital for viral replication but can also contribute to oncogenesis and cancer development in some cases [16].

The Wnt signaling pathway is one such critical network that viruses have been shown to modulate. Viruses interact with this pathway through various mechanisms, including epigenetic modifications of Wnt genes, targeting specific Wnt pathway members, and altering β-catenin nuclear translocation, which leads to the activation of Wnt signaling. This modulation can result in the dysregulation of cell growth and differentiation, thereby contributing to viral pathogenesis and potentially cancer [16].

Moreover, viral infections can also induce significant remodeling of host cell metabolism. For example, several studies have highlighted how viruses manipulate metabolic pathways, including glucose, fatty acid, and protein metabolism, to enhance their replication. This includes the mimicry of host hormones, such as insulin, by viral peptides, which can lead to alterations in the host's endocrine system and metabolic processes [17].

The immune response is another crucial aspect that viruses manipulate to their advantage. By subverting host immune signaling pathways, viruses can evade detection and destruction by the immune system. For example, viruses may induce the expression of specific host proteins that inhibit antiviral responses or promote cell survival, allowing for persistent infection [18].

Additionally, the interactions between viral proteins and host factors can disrupt the normal signaling pathways that regulate cell death. Viruses can induce apoptosis, necrosis, or pyroptosis in infected cells, which serves both as a defense mechanism by the host and as a strategy for the virus to spread to new cells [18].

In summary, the manipulation of host cell signaling pathways is a central mechanism of viral pathogenesis. By hijacking these pathways, viruses can alter host metabolism, evade immune responses, and promote their own replication, which can lead to disease progression and, in some cases, cancer development. Understanding these interactions is crucial for developing targeted therapeutic strategies to combat viral infections and their associated pathologies.

3 Viral Families and Their Pathogenic Mechanisms ​

3.1 RNA Viruses ​

Viral pathogenesis is a complex process that involves intricate interactions between viruses and their host organisms. RNA viruses, which encompass a diverse array of pathogens responsible for significant human diseases, utilize various mechanisms to establish infection, evade host defenses, and induce disease. The following outlines key pathogenic mechanisms employed by RNA viruses.

  1. Genomic Structure and Protein Encoding: RNA viruses often possess compact genomes that allow for multiple overlapping reading frames. This genomic architecture facilitates the encoding of various proteins through mechanisms such as alternative splicing and ribosomal frameshifting, enabling the production of distinct proteins essential for viral replication and pathogenesis [19].

  2. Manipulation of Host Cellular Machinery: RNA viruses hijack host cellular processes to promote their replication. For instance, they co-opt host factors involved in membrane trafficking and lipid metabolism to form viral replication complexes (VRCs), which are crucial for viral genome replication and protein synthesis [7]. Additionally, RNA viruses can manipulate ribosomes and translation initiation factors to favor the synthesis of viral proteins over host immune proteins, thereby enhancing viral protein production and inhibiting antiviral responses [20].

  3. Induction of DNA Damage Response (DDR): Some RNA viruses can induce DNA damage in host cells, even when their replication occurs solely in the cytoplasm. This DNA damage can trigger apoptosis, stimulate inflammatory responses, and introduce mutations that may lead to tumorigenesis [21]. Moreover, the activation of DDR pathways can paradoxically facilitate viral RNA genome replication, illustrating a dual role in pathogenesis [21].

  4. Evasion of Innate Immune Responses: RNA viruses have evolved numerous strategies to evade the host's innate immune system, particularly the interferon response. By interfering with the recognition of viral components and disrupting signaling pathways that initiate antiviral responses, these viruses enhance their replication capacity [22]. For example, positive-sense single-stranded RNA viruses have developed molecular mechanisms to antagonize host immune responses, which can have complex implications for disease outcomes [22].

  5. Cytopathic Effects and Host Gene Expression Inhibition: RNA viruses can induce cytopathic effects, leading to changes in cell morphology and function. This cytopathogenesis includes the inhibition of host gene expression, which is often aimed at suppressing antiviral responses and facilitating viral replication [9]. For example, certain RNA viruses express multifunctional proteins that modulate host responses, thereby contributing to disease severity [23].

  6. Pathogen-Host Interactions: The interactions between viral RNAs and host factors are critical for pathogenesis. RNA viruses can utilize specific RNA sequences and secondary structures to influence virulence and the host's immune response. This RNA-mediated pathogenesis is a significant area of study, particularly for alphaviruses, where viral RNAs play a pivotal role in determining the outcome of infection [24].

  7. Environmental Adaptation and Quasispecies Dynamics: RNA viruses exhibit high mutation rates, leading to the formation of quasispecies. This genetic diversity allows RNA viruses to rapidly adapt to environmental changes, including host immune pressures. The ability to generate a diverse pool of viral variants enhances the likelihood of survival and replication in fluctuating environments [25].

In summary, RNA viruses employ a multifaceted array of mechanisms to establish infection, evade host defenses, and induce disease. These mechanisms include manipulating host cellular processes, inducing DNA damage, evading immune responses, and altering host gene expression. Understanding these pathogenic strategies is crucial for developing effective antiviral therapies and vaccines against RNA virus-induced diseases.

3.2 DNA Viruses ​

Viral pathogenesis, particularly concerning DNA viruses, involves complex interactions between the virus and host cellular mechanisms. DNA viruses utilize various strategies to manipulate host cellular processes, which ultimately facilitate their replication and contribute to disease development.

One significant mechanism of viral pathogenesis is the ability of DNA viruses to interfere with the host's cell cycle control and apoptosis pathways. For instance, oncogenic DNA viruses can express proteins that disrupt the normal regulation of cell growth and survival. These viral proteins can target key cellular pathways, such as those involving tumor suppressor genes like p53 and Retinoblastoma (RB), thereby blocking apoptosis and promoting enhanced viral replication. The dysregulation of apoptosis is critical as it allows the virus to evade host defenses and sustain its lifecycle, potentially leading to carcinogenesis in the infected host [26].

Moreover, DNA viruses have evolved mechanisms to hijack the host's DNA damage response (DDR). They can manipulate cellular replication and repair processes to favor their own replication. This interaction often results in the activation of host DNA repair pathways, which the viruses exploit to facilitate their replication while also potentially inducing genomic instability in the host. Such interactions underscore the dual role of DNA viruses in both promoting their own lifecycle and contributing to host cell damage [27].

In addition to manipulating apoptosis and the DDR, DNA viruses can form specialized structures within the host cell known as viral replication compartments (VRCs). These membraneless assemblies are crucial for organizing viral processes and optimizing the interaction between viral components and host factors. By creating VRCs, DNA viruses can effectively sequester necessary cellular machinery for their replication while evading host immune responses [28].

Another critical aspect of DNA viral pathogenesis is the evasion of host immune responses. DNA viruses can employ various strategies to avoid detection by the host's immune system. For example, they may manipulate host immune factors or utilize viral mimicry to subvert the innate immune response, thereby prolonging infection and enhancing their pathogenic potential [29].

Overall, the pathogenesis of DNA viruses is characterized by their ability to co-opt host cellular mechanisms, evade immune detection, and disrupt normal cellular processes. Understanding these intricate interactions not only provides insight into viral biology but also informs the development of antiviral therapies and strategies for managing viral diseases.

3.3 Retroviruses ​

Retroviruses are a diverse family of viruses that can cause a wide range of diseases in humans and animals, including some cancers and immunodeficiency syndromes. The mechanisms of viral pathogenesis associated with retroviruses involve various complex processes that can disrupt normal cellular functions and provoke immune responses.

One primary mechanism of pathogenesis is the integration of retroviral DNA into the host genome. This integration allows the virus to persist within the host and can lead to the activation of oncogenes or disruption of tumor suppressor genes, contributing to tumorigenesis. For instance, the human T cell leukemia viruses (HTLV-I and HTLV-II) are known to induce leukemia and neurological disorders through such mechanisms. These viruses express regulatory proteins like Tax and Rex, which are crucial for viral gene expression and the pathogenesis of associated diseases (Green & Chen, 1990) [30].

Moreover, retroviruses can exploit cellular processes to facilitate their own replication and dissemination. Myeloid cells, for example, can enhance viral spread without being productively infected themselves. The interaction of HIV-1 with Siglec-1/CD169 on myeloid cells illustrates this point, as it enables the virus to capture and infect bystander target cells, thereby promoting disease progression (Martinez-Picado et al., 2017) [31].

The role of endogenous retroviruses (ERVs) in pathogenesis is also significant. ERVs, remnants of ancient retroviral infections that have integrated into the germline, can be reactivated under certain conditions, potentially contributing to autoimmune diseases. For example, in systemic lupus erythematosus (SLE), both exogenous and endogenous retroviruses may influence the immune response, leading to disease manifestations (Talotta et al., 2020) [32].

Another aspect of retroviral pathogenesis involves the modulation of immune responses. Retroviruses can evade the host immune system through rapid mutation and the establishment of latency, making it difficult for the immune system to mount an effective response. This evasion can result in chronic infections and associated pathologies, as seen in HIV infection, where the virus progressively destroys CD4+ T cells, leading to immunodeficiency (Wiley, 1994) [33].

In addition to immune evasion, retroviruses can alter the function of host cells by manipulating cellular signaling pathways. The interaction between viral proteins and host cell factors can lead to cellular dysregulation, contributing to disease pathology. For example, the expression of viral proteins can trigger inflammatory pathways or disrupt normal apoptotic processes, leading to tissue damage and disease (Löwer, 1999) [34].

Overall, the pathogenic mechanisms of retroviruses are multifaceted, involving genomic integration, immune modulation, and cellular manipulation, which together contribute to the diverse array of diseases associated with this viral family. Understanding these mechanisms is crucial for developing targeted therapies and interventions against retroviral infections and their associated pathologies.

4 Host Factors Influencing Viral Pathogenesis ​

4.1 Genetic Susceptibility ​

Viral pathogenesis is influenced by a complex interplay between viral factors and host factors, with genetic susceptibility playing a significant role in determining the outcomes of viral infections. Understanding these mechanisms is crucial for developing therapeutic strategies and preventive measures against viral diseases.

Host genetic factors contribute to susceptibility or resistance to various viral infections. Research has shown that specific genetic variants can significantly influence the host's immune response, thereby affecting disease severity and progression. For instance, in the context of human immunodeficiency virus (HIV) infection, variations in genes associated with the major histocompatibility complex (MHC) can modulate immune responses and influence the course of the disease (Schmidt et al., 2022) [35]. The CCR5 co-receptor, known for its role in HIV entry into cells, has a common variant (CCR5Δ32) that can lead to a loss of function, thereby providing resistance to HIV infection (Vannberg et al., 2011) [36].

Moreover, the immune system's delicate balance between innate and adaptive responses is pivotal in controlling viral replication. Genetic variations can impact cytokine responses, which are critical for mounting an effective antiviral response. For example, variations in genes involved in cytokine production can influence the severity of respiratory viral infections such as influenza and respiratory syncytial virus (Forbester and Humphreys, 2021) [37]. Overactive cytokine responses can lead to excessive inflammation, contributing to disease severity, while insufficient responses may allow the virus to replicate unchecked.

Additionally, host genetic factors can affect the expression and function of viral receptors and immune-related proteins. These genetic determinants can dictate how effectively the immune system recognizes and responds to viral infections, ultimately influencing the pathogenesis of diseases such as hepatitis B and C, where host genetics plays a role in viral clearance and chronicity (Kenney et al., 2017) [38].

The interplay between host genetics and viral factors also highlights the role of co-opted host mechanisms in viral replication and pathogenesis. For example, some viruses exploit host cellular machinery to establish replication complexes, which are essential for their life cycle (Hyodo and Okuno, 2016) [7]. Understanding these interactions can provide insights into the molecular basis of viral pathogenesis and inform the development of antiviral therapies.

In summary, genetic susceptibility to viral infections is shaped by a myriad of host factors, including variations in immune-related genes, receptor expression, and cytokine responses. These factors not only influence the host's ability to mount an effective immune response but also determine the overall pathogenesis of viral diseases. Continued research into the genetic determinants of viral pathogenesis is essential for advancing therapeutic strategies and improving patient outcomes in infectious diseases.

4.2 Environmental Influences ​

Viral pathogenesis is a multifaceted process influenced by various host factors and environmental conditions. Understanding these mechanisms is crucial for developing effective therapeutic strategies against viral infections.

Host factors play a significant role in viral pathogenesis, as viruses must exploit the host's cellular machinery for their replication and survival. For instance, p53, a well-known tumor suppressor protein, is involved in regulating cellular pathways related to immune responses and genomic integrity. Some viruses have evolved mechanisms to subvert p53 functions, either by degrading or sequestering the protein, or by utilizing its functions to facilitate their own replication. This interplay between viral proteins and host factors is essential for establishing effective pathogenesis and highlights the complex dynamics at play during viral infections [39].

Moreover, the immune system, encompassing both innate and adaptive responses, acts as a double-edged sword in viral infections. Insufficient immune responses may allow pathogens to establish persistent infections, while excessive activation can lead to organ damage. The innate immune response, triggered by pathogen-associated molecular patterns (PAMPs) recognized by pattern recognition receptors (PRRs), plays a critical role in defending against viral infections. Variability in the expression of PRRs and the induction of interferon-stimulated genes (ISGs) across different cell types can significantly affect the outcome of viral infections [40].

Environmental factors also modulate viral pathogenesis. The influence of environmental chemicals on antiviral immunity is increasingly recognized. Studies have shown that certain chemical exposures can lead to poorer health outcomes, increased infection rates, and diminished vaccine responses. However, the underlying mechanisms remain poorly understood, indicating a need for further investigation into how environmental exposures can impact viral defenses and disease outcomes [41].

Additionally, ecological factors play a role in the emergence and evolution of viral diseases. Viruses are capable of genetic changes, allowing them to adapt to new host species and environments. This adaptability is driven by mutations, recombination, and reassortment, which generate diverse viral populations that can be selected under varying ecological conditions. Such dynamics are particularly evident in zoonotic viruses, which can jump from animals to humans, leading to novel infections [42].

In summary, the mechanisms of viral pathogenesis are influenced by a combination of host factors, including immune responses and cellular machinery, as well as environmental influences that can modulate these interactions. Understanding these complex relationships is essential for identifying new therapeutic targets and improving strategies for the prevention and treatment of viral diseases.

5 Therapeutic Implications and Future Directions ​

5.1 Current Therapeutic Approaches ​

Viral pathogenesis is a multifaceted process that involves complex interactions between viruses and host cells, leading to disease development. The mechanisms of viral pathogenesis can be broadly categorized into several key processes:

  1. Virus Entry and Replication: Viruses exploit host cell mechanisms to gain entry and replicate. For instance, the interaction between viral proteins and host cell receptors is critical for virus entry into the cell. Once inside, viruses hijack the host's cellular machinery for their replication, often leading to cellular dysfunction and death. This includes the activation of intrinsic cell death pathways and immune-mediated injuries, as observed in hepatitis virus infections, where the immune response can cause significant hepatocellular damage alongside direct viral effects (Woo et al. 2024) [40].

  2. Immune Evasion: Many viruses have evolved sophisticated strategies to evade the host immune response. This can include the modulation of immune signaling pathways, suppression of interferon responses, and the alteration of antigen presentation. For example, certain viral proteins can inhibit the recognition of pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors (PRRs), which diminishes the host's ability to mount an effective antiviral response (Woo et al. 2024) [40].

  3. Induction of Chronic Infection: Some viruses can establish persistent infections, often leading to chronic diseases. This is facilitated by mechanisms that allow viruses to evade immune detection over extended periods. Chronic hepatitis B and C infections are prime examples, where the viruses manipulate host metabolic pathways to ensure their survival (Quirino et al. 2024) [6].

  4. Cellular Dysregulation and Damage: Viral infections can lead to dysregulation of cellular processes, including apoptosis, proliferation, and immune activation. The interplay between viral replication and the host's immune response can result in tissue damage, as seen in severe cases of dengue and other viral infections, where the extent of viraemia correlates with disease severity (Malavige & Ogg 2024) [43].

The therapeutic implications of understanding these mechanisms are significant. By identifying the specific pathways and interactions involved in viral pathogenesis, new therapeutic strategies can be developed. Current therapeutic approaches include:

  1. Antiviral Therapies: These target various stages of the viral life cycle, from entry inhibitors to drugs that interfere with viral replication. For example, antiviral gene therapy is being explored to disable pathogen replication through engineered nucleic acids (Akram et al. 2023) [44].

  2. Therapeutic Vaccination: There is a growing interest in therapeutic vaccines that aim to boost the immune response against chronic viral infections. These vaccines can potentially replace or augment existing therapies by harnessing the host's immune mechanisms to control viral replication (Vandepapelière 2002) [45].

  3. Immunotherapy: Strategies such as immune checkpoint inhibitors and adoptive cell therapies are being investigated to enhance the immune response against virus-associated cancers and chronic infections (Santana-Davila et al. 2017) [14].

  4. Combination Therapies: Utilizing a combination of antiviral agents and immunotherapies may provide a more effective treatment strategy, particularly for persistent infections where single-agent therapies have failed (Pagliano et al. 2025) [46].

Future directions in the field should focus on enhancing our understanding of the nuanced interactions between viruses and host cells, identifying reliable biomarkers for disease progression, and developing more targeted therapeutic interventions. The integration of novel technologies such as spatial transcriptomics could further illuminate the complex dynamics of virus-host interactions, paving the way for innovative treatment strategies (Holdener et al. 2025) [47].

5.2 Future Research Directions ​

Viral pathogenesis involves a complex interplay between viruses and host cells, with mechanisms that can lead to disease and various clinical outcomes. The understanding of these mechanisms is crucial for developing therapeutic strategies and addressing future research directions.

The pathogenesis of viral infections typically encompasses several key processes: virus entry into host cells, replication, evasion of immune responses, and induction of cellular damage. For instance, hepatitis viruses exploit metabolic and cell signaling pathways to facilitate their entry and replication within hepatocytes, leading to hepatocellular damage [6]. Similarly, the pathogenesis of long COVID, characterized by persistent symptoms post-SARS-CoV-2 infection, is multifactorial, involving mechanisms such as endothelial dysfunction, chronic inflammation, and immune dysregulation [46]. These insights underscore the need to dissect the specific pathways utilized by different viruses to enhance therapeutic targeting.

A significant aspect of viral pathogenesis is the interaction between viral products and the host immune system. The immune response can be both protective and detrimental; insufficient immune activation may allow for persistent infection, while excessive activation can lead to tissue damage [40]. The activation of pattern recognition receptors (PRRs) in response to viral pathogen-associated molecular patterns (PAMPs) is essential for initiating the innate immune response, which includes the induction of interferon-stimulated genes (ISGs) [40]. This duality of immune response necessitates a balanced approach in therapeutic development, aiming to enhance protective immunity while minimizing potential tissue damage.

Future research directions should focus on several key areas to improve therapeutic outcomes against viral infections. Firstly, the identification of reliable biomarkers for early diagnosis and monitoring of viral diseases is critical, particularly for conditions like long COVID where current diagnostic tools are limited [46]. Secondly, understanding the genetic, epigenetic, and environmental factors that influence individual susceptibility to viral infections can inform personalized therapeutic approaches [6].

Additionally, advancements in imaging technologies and spatial transcriptomics hold promise for elucidating the mechanisms of virus dissemination and host interactions in vivo [47][48]. These technologies can facilitate a more comprehensive understanding of viral pathogenesis at the cellular and tissue levels, potentially leading to the discovery of novel therapeutic targets.

Moreover, there is a growing interest in therapeutic vaccination strategies for chronic viral infections, which could harness the immune system more effectively [45]. Exploring the mechanisms of viral evasion of the immune system will be essential for optimizing immunotherapeutic approaches, particularly in virus-associated cancers [14].

In summary, a multifaceted approach that integrates insights from molecular virology, immunology, and therapeutic development will be essential in advancing our understanding of viral pathogenesis and in formulating effective treatment strategies. Addressing the gaps in knowledge regarding host-virus interactions and the immune response will be critical for developing innovative therapies to combat viral diseases.

6 Conclusion ​

This review highlights the multifaceted mechanisms of viral pathogenesis, emphasizing the complex interactions between viral factors and host responses. Key findings indicate that viruses employ direct cytopathic effects, immune evasion strategies, and manipulation of host cell signaling pathways to establish infection and induce disease. The evaluation of current research reveals significant advancements in understanding how different viral families—such as RNA viruses, DNA viruses, and retroviruses—exploit host cellular machinery to promote their replication and survival. Furthermore, genetic susceptibility and environmental influences play crucial roles in modulating disease outcomes, underscoring the importance of personalized approaches in therapeutic strategies. Future research directions should focus on elucidating the intricate dynamics of host-virus interactions, identifying novel therapeutic targets, and improving diagnostic tools to enhance patient outcomes. By addressing these areas, we can pave the way for innovative solutions to combat viral infections and their associated diseases.

References ​

  • [1] Laura Gragnani;Alessia Piluso;Elisa Fognani;Anna Linda Zignego. MicroRNA expression in hepatitis C virus-related malignancies: A brief review.. World journal of gastroenterology(IF=5.4). 2015. PMID:26229398. DOI: 10.3748/wjg.v21.i28.8562.
  • [2] Matthew S Durstenfeld;Shannon Weiman;Michael Holtzman;Catherine Blish;Resia Pretorius;Steven G Deeks. Long COVID and post-acute sequelae of SARS-CoV-2 pathogenesis and treatment: A Keystone Symposia report.. Annals of the New York Academy of Sciences(IF=4.8). 2024. PMID:38593220. DOI: 10.1111/nyas.15132.
  • [3] D J Granville;C M Carthy;D Yang;D W Hunt;B M McManus. Interaction of viral proteins with host cell death machinery.. Cell death and differentiation(IF=15.4). 1998. PMID:10200520. DOI: 10.1038/sj.cdd.4400388.
  • [4] Shayla Grace Verburg;Rebecca Margaret Lelievre;Michael James Westerveld;Jordon Marcus Inkol;Yi Lin Sun;Samuel Tekeste Workenhe. Viral-mediated activation and inhibition of programmed cell death.. PLoS pathogens(IF=4.9). 2022. PMID:35951530. DOI: 10.1371/journal.ppat.1010718.
  • [5] Koichi Watashi;Kunitada Shimotohno. The roles of hepatitis C virus proteins in modulation of cellular functions: a novel action mechanism of the HCV core protein on gene regulation by nuclear hormone receptors.. Cancer science(IF=4.3). 2003. PMID:14611668. DOI: 10.1111/j.1349-7006.2003.tb01381.x.
  • [6] Angela Quirino;Nadia Marascio;Francesco Branda;Alessandra Ciccozzi;Chiara Romano;Chiara Locci;Ilenia Azzena;Noemi Pascale;Grazia Pavia;Giovanni Matera;Marco Casu;Daria Sanna;Marta Giovanetti;Giancarlo Ceccarelli;Pierfrancesco Alaimo di Loro;Massimo Ciccozzi;Fabio Scarpa;Antonello Maruotti. Viral Hepatitis: Host Immune Interaction, Pathogenesis and New Therapeutic Strategies.. Pathogens (Basel, Switzerland)(IF=3.3). 2024. PMID:39338957. DOI: 10.3390/pathogens13090766.
  • [7] Kiwamu Hyodo;Tetsuro Okuno. Pathogenesis mediated by proviral host factors involved in translation and replication of plant positive-strand RNA viruses.. Current opinion in virology(IF=5.1). 2016. PMID:26651023. DOI: 10.1016/j.coviro.2015.11.004.
  • [8] J A Zaia. Epidemiology and pathogenesis of cytomegalovirus disease.. Seminars in hematology(IF=4.1). 1990. PMID:2160129. DOI: .
  • [9] D S Lyles. Cytopathogenesis and inhibition of host gene expression by RNA viruses.. Microbiology and molecular biology reviews : MMBR(IF=7.8). 2000. PMID:11104816. DOI: 10.1128/MMBR.64.4.709-724.2000.
  • [10] Cindy Chiang;Guanqun Liu;Michaela U Gack. Viral Evasion of RIG-I-Like Receptor-Mediated Immunity through Dysregulation of Ubiquitination and ISGylation.. Viruses(IF=3.5). 2021. PMID:33530371. DOI: 10.3390/v13020182.
  • [11] Ying Kai Chan;Michaela U Gack. Viral evasion of intracellular DNA and RNA sensing.. Nature reviews. Microbiology(IF=103.3). 2016. PMID:27174148. DOI: 10.1038/nrmicro.2016.45.
  • [12] Yanan Wu;Zhuoya Sun;Lu Xia;Panpan Tian;Liuyang Jiao;Yanze Li;Zhanyong Wei;Xuannian Wang;Xiaoying Li;Gaiping Zhang. MHC-I pathway disruption by viruses: insights into immune evasion and vaccine design for animals.. Frontiers in immunology(IF=5.9). 2025. PMID:40406104. DOI: 10.3389/fimmu.2025.1540159.
  • [13] Marni S Crow;Krystal K Lum;Xinlei Sheng;Bokai Song;Ileana M Cristea. Diverse mechanisms evolved by DNA viruses to inhibit early host defenses.. Critical reviews in biochemistry and molecular biology(IF=6.4). 2016. PMID:27650455. DOI: 10.1080/10409238.2016.1226250.
  • [14] Rafael Santana-Davila;Shailender Bhatia;Laura Q M Chow. Harnessing the Immune System as a Therapeutic Tool in Virus-Associated Cancers.. JAMA oncology(IF=20.1). 2017. PMID:27812682. DOI: 10.1001/jamaoncol.2016.4574.
  • [15] Scheilla T Strumillo;Denis Kartavykh;Fábio F de Carvalho;Nicolly C Cruz;Ana C de Souza Teodoro;Ricardo Sobhie Diaz;Marli F Curcio. Host-virus interaction and viral evasion.. Cell biology international(IF=3.1). 2021. PMID:33533523. DOI: 10.1002/cbin.11565.
  • [16] Wendy J van Zuylen;William D Rawlinson;Caroline E Ford. The Wnt pathway: a key network in cell signalling dysregulated by viruses.. Reviews in medical virology(IF=6.6). 2016. PMID:27273590. DOI: 10.1002/rmv.1892.
  • [17] Khyati Girdhar;Amaya Powis;Amol Raisingani;Martina Chrudinová;Ruixu Huang;Tu Tran;Kaan Sevgi;Yusuf Dogus Dogru;Emrah Altindis. Viruses and Metabolism: The Effects of Viral Infections and Viral Insulins on Host Metabolism.. Annual review of virology(IF=8.3). 2021. PMID:34586876. DOI: 10.1146/annurev-virology-091919-102416.
  • [18] Mohamed Lamkanfi;Vishva M Dixit. Manipulation of host cell death pathways during microbial infections.. Cell host & microbe(IF=18.7). 2010. PMID:20638641. DOI: 10.1016/j.chom.2010.06.007.
  • [19] Matthew F Allan;Amir Brivanlou;Silvi Rouskin. RNA levers and switches controlling viral gene expression.. Trends in biochemical sciences(IF=11.0). 2023. PMID:36710231. DOI: 10.1016/j.tibs.2022.12.002.
  • [20] Xiao Wang;Jie Zhu;Da Zhang;Guangqing Liu. Ribosomal control in RNA virus-infected cells.. Frontiers in microbiology(IF=4.5). 2022. PMID:36419416. DOI: 10.3389/fmicb.2022.1026887.
  • [21] Ellis L Ryan;Robert Hollingworth;Roger J Grand. Activation of the DNA Damage Response by RNA Viruses.. Biomolecules(IF=4.8). 2016. PMID:26751489. DOI: .
  • [22] Tessa Nelemans;Marjolein Kikkert. Viral Innate Immune Evasion and the Pathogenesis of Emerging RNA Virus Infections.. Viruses(IF=3.5). 2019. PMID:31635238. DOI: 10.3390/v11100961.
  • [23] Michelle M Arnold;Adrish Sen;Harry B Greenberg;John T Patton. The battle between rotavirus and its host for control of the interferon signaling pathway.. PLoS pathogens(IF=4.9). 2013. PMID:23359266. DOI: 10.1371/journal.ppat.1003064.
  • [24] Autumn T LaPointe;Kevin J Sokoloski. De-Coding the Contributions of the Viral RNAs to Alphaviral Pathogenesis.. Pathogens (Basel, Switzerland)(IF=3.3). 2021. PMID:34205345. DOI: 10.3390/pathogens10060771.
  • [25] Kanerva; Mustonen; Vaheri. Pathogenesis of puumala and other hantavirus infections.. Reviews in medical virology(IF=6.6). 1998. PMID:10398496. DOI: 10.1002/(sici)1099-1654(199804/06)8:2<67::aid-rmv217>3.0.co;2-u.
  • [26] Y Cheng. Human DNA oncogenic viruses and their transforming protein interactions with cell cycle control proteins.. Chinese medical journal(IF=7.3). 1999. PMID:11593524. DOI: .
  • [27] Matthew D Weitzman;Amélie Fradet-Turcotte. Virus DNA Replication and the Host DNA Damage Response.. Annual review of virology(IF=8.3). 2018. PMID:29996066. DOI: 10.1146/annurev-virology-092917-043534.
  • [28] Matthew Charman;Matthew D Weitzman. Replication Compartments of DNA Viruses in the Nucleus: Location, Location, Location.. Viruses(IF=3.5). 2020. PMID:32013091. DOI: 10.3390/v12020151.
  • [29] Sandra Huérfano;Vojtech Šroller;Kateřina Bruštíková;Lenka Horníková;Jitka Forstová. The Interplay between Viruses and Host DNA Sensors.. Viruses(IF=3.5). 2022. PMID:35458396. DOI: 10.3390/v14040666.
  • [30] P L Green;I S Chen. Regulation of human T cell leukemia virus expression.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology(IF=4.2). 1990. PMID:2404818. DOI: 10.1096/fasebj.4.2.2404818.
  • [31] Javier Martinez-Picado;Paul J McLaren;Amalio Telenti;Nuria Izquierdo-Useros. Retroviruses As Myeloid Cell Riders: What Natural Human Siglec-1 "Knockouts" Tell Us About Pathogenesis.. Frontiers in immunology(IF=5.9). 2017. PMID:29209326. DOI: 10.3389/fimmu.2017.01593.
  • [32] Rossella Talotta;Fabiola Atzeni;Magdalena Janina Laska. Retroviruses in the pathogenesis of systemic lupus erythematosus: Are they potential therapeutic targets?. Autoimmunity(IF=3.1). 2020. PMID:32321325. DOI: 10.1080/08916934.2020.1755962.
  • [33] C A Wiley. Pathology of neurologic disease in AIDS.. The Psychiatric clinics of North America(IF=3.4). 1994. PMID:8190660. DOI: .
  • [34] R Löwer. The pathogenic potential of endogenous retroviruses: facts and fantasies.. Trends in microbiology(IF=14.9). 1999. PMID:10470042. DOI: 10.1016/s0966-842x(99)01565-6.
  • [35] Axel Schmidt;Ana M Groh;Julia S Frick;Maria J G T Vehreschild;Kerstin U Ludwig. Genetic Predisposition and the Variable Course of Infectious Diseases.. Deutsches Arzteblatt international(IF=7.1). 2022. PMID:35101171. DOI: .
  • [36] Fredrik O Vannberg;Stephen J Chapman;Adrian V S Hill. Human genetic susceptibility to intracellular pathogens.. Immunological reviews(IF=8.3). 2011. PMID:21349089. DOI: 10.1111/j.1600-065X.2010.00996.x.
  • [37] Jessica L Forbester;Ian R Humphreys. Genetic influences on viral-induced cytokine responses in the lung.. Mucosal immunology(IF=7.6). 2021. PMID:33184476. DOI: 10.1038/s41385-020-00355-6.
  • [38] Adam D Kenney;James A Dowdle;Leonia Bozzacco;Temet M McMichael;Corine St Gelais;Amanda R Panfil;Yan Sun;Larry S Schlesinger;Matthew Z Anderson;Patrick L Green;Carolina B López;Brad R Rosenberg;Li Wu;Jacob S Yount. Human Genetic Determinants of Viral Diseases.. Annual review of genetics(IF=8.6). 2017. PMID:28853921. DOI: 10.1146/annurev-genet-120116-023425.
  • [39] Apala Pal;Sachin Kumar Tripathi;Priya Rani;Meghana Rastogi;Saumitra Das. p53 and RNA viruses: The tug of war.. Wiley interdisciplinary reviews. RNA(IF=4.8). 2023. PMID:37985142. DOI: 10.1002/wrna.1826.
  • [40] Yein Woo;Muyuan Ma;Masashi Okawa;Takeshi Saito. Hepatocyte Intrinsic Innate Antiviral Immunity against Hepatitis Delta Virus Infection: The Voices of Bona Fide Human Hepatocytes.. Viruses(IF=3.5). 2024. PMID:38793622. DOI: 10.3390/v16050740.
  • [41] Anthony M Franchini;B Paige Lawrence. Environmental exposures are hidden modifiers of anti-viral immunity.. Current opinion in toxicology(IF=3.6). 2018. PMID:30035244. DOI: 10.1016/j.cotox.2018.01.004.
  • [42] Esteban Domingo. Mechanisms of viral emergence.. Veterinary research(IF=3.5). 2010. PMID:20167200. DOI: 10.1051/vetres/2010010.
  • [43] Gathsaurie Neelika Malavige;Graham S Ogg. Immune responses and severe dengue: what have we learned?. Current opinion in infectious diseases(IF=4.0). 2024. PMID:39079180. DOI: 10.1097/QCO.0000000000001040.
  • [44] Fatima Akram;Hafiza Marium Waheed;Fatima Iftikhar Shah;Ikram Ul Haq;Narmeen Nasir;Muhammad Tayyab Akhtar;Umar Farooq Gohar. Burgeoning therapeutic strategies to curb the contemporary surging viral infections.. Microbial pathogenesis(IF=3.5). 2023. PMID:37004965. DOI: 10.1016/j.micpath.2023.106088.
  • [45] Pierre Vandepapelière. Therapeutic vaccination against chronic viral infections.. The Lancet. Infectious diseases(IF=31.0). 2002. PMID:12144898. DOI: 10.1016/s1473-3099(02)00289-x.
  • [46] Pasquale Pagliano;Flora Salzano;Chiara D'Amore;Annamaria Spera;Valeria Conti;Veronica Folliero;Gianluigi Franci;Tiziana Ascione. How do drug discovery scientists address the unmet need of long COVID syndrome therapeutics and what more can be done?. Expert opinion on drug discovery(IF=4.9). 2025. PMID:40660830. DOI: 10.1080/17460441.2025.2534056.
  • [47] Chase Holdener;Shaowen Jiang;Danica M Sutherland;Kira A Griswold;Terence S Dermody;John S L Parker;Iwijn De Vlaminck. Spatial Transcriptomics to Study Virus-Host Interactions.. Annual review of virology(IF=8.3). 2025. PMID:40523107. DOI: 10.1146/annurev-virology-092623-104926.
  • [48] Pradeep D Uchil;Kelsey A Haugh;Ruoxi Pi;Walther Mothes. In Vivo Imaging-Driven Approaches to Study Virus Dissemination and Pathogenesis.. Annual review of virology(IF=8.3). 2019. PMID:31283440. DOI: 10.1146/annurev-virology-101416-041429.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

Viral Pathogenesis · Immune Evasion · Host Cell Signaling Pathways

© 2025 MaltSci